| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Mar―23 |
Tunable Morphology of Au Nanostars Enhances Dual-Modal Lateral Flow Immunoassay for Sensitive SARS-CoV-2 Antibody Detection |
Yunbing Jiao, Jie Zhang, Jingwen Li, Jingbin Zeng |
| 2 |
[GO] |
2025―Jul―16 |
Beyond immune escape in SARS-CoV-2: an ACE2-functionalized gold nanoparticle vertical flow assay for saliva-based detection |
Tejal Dube, Puja Prasad, Chandra Shekhar Kumar, Manidipa Banerjee, Manojkumar Ramteke |
| 3 |
[GO] |
2024―Dec―13 |
Eco-friendly Fenton reagents-based negative ζ potential engineering on porous carbon materials and its application on effective removal of methylene blue and SARS-CoV-2 virus by enhanced electrostatic interaction |
Keyang Li, Bo Sun, Zhiqing Xu, Mengda Hou, Chun Li, Quanquan Pan, Jianning Gan, Yilun Huang, Qiang Ding, Ming Zhao, Daming Zhuang, Qianming Gong |
| 4 |
[GO] |
2024―Nov―06 |
Synthesis of naphthoquinone-fused enediyne sugar polysulfates for nanomolar inhibition of coronavirus |
Xiaohua Huang, Jing Miao, Hongyu Zheng, Lingjing Mao, Zhe Ding, Xinyu Yu, Jingtao Xu, Jiaming Lan, Aiguo Hu |
| 5 |
[GO] |
2024―Nov―06 |
Computational Discovery of SARS-CoV-2 Main Protease Inhibitors Via a Virtual Screening, Molecular Docking, Molecular Dynamics and MM/PBSA Calculations-Driven Approach |
Sheng-Qi Huang, Yan-Jun Zhang, Zhonghua Wang, Fei Xiong |
| 6 |
[GO] |
2024―Oct―01 |
Synthesis of acyclic analogues of adenosine sulfonamides and their activity against RNA cap guanine N7-methyltransferase of SARS-CoV-2 |
Rostom Ahmed-Belkacem, Adrien Delpal, Bruno Canard, Jean-Jacques Vasseur, Etienne DECROLY, Françoise Debart |
| 7 |
[GO] |
2024―Aug―14 |
Design and synthesis of copper(ii) and nickel(ii) complexes as potential inhibitors against SARS-CoV-2 viral RNA binding protein and Omicron RBD protein |
Reyaz Ahmad, Mukesh Choudhary |
| 8 |
[GO] |
2024―Jul―30 |
Quinoxaline Derivatives as Potent Compounds against Both 3CLpro and PLpro Enzymes of SARS-CoV-2 virus: An Insight from Experimental and Theoretical Approaches |
Nazanin Norozi Shad, Hossein Sabet-Sarvestani, vahid moghimi, Toktam Afrough, Kamahldin Haghbeen, Hossein Eshghi |
| 9 |
[GO] |
2024―May―04 |
Nano-Crystallites of Ruthenium(III) Violurate Complex: Synthesis, Characterization, PXRD and DFT Structural Analysis. DNA/ HSA -Binding, Antiviral Activity Against COVID-19 and Molecular Docking Study |
Abdulrahman Alhadhrami |
| 10 |
[GO] |
2024―May―03 |
Synthesis of Zn(ii) coordination complexes, their molecular design and docking with SARS-CoV-2 RBD protein and Omicron spike protein |
Simranjeet Singh, Mukesh Choudhary |
| 11 |
[GO] |
2024―Feb―09 |
A heparan sulfate proteoglycan-mimicking AIE fluorescent probe for SARS-CoV-2 detection |
Fang Liu, Yue Huang, Yutong Li, Yongcheng Chen, Qiao Jin, Jian Ji |
| 12 |
[GO] |
2024―Jan―12 |
A new Cu(ii) complex derived from the reaction between tris(2-aminoethyl)amine and Cu(i)-activated acetonitrile with potent anticancer activity against some cell lines and high affinity for the essential proteins of SARS-CoV-2 |
Farshid Hajibabaei, Sadegh Salehzadeh, Katayoun Derakhshandeh, Robert William Gable |
| 13 |
[GO] |
2023―Dec―18 |
Design and numerical-phase analysis of an SPR system for direct detection of SARS-CoV-2 virus in pharyngeal swab solution |
Yansheng Liu, Junpeng Deng, Xiaobo Jia, Jin Zhou, Hongli Li, Xiaohong Wang, Yating Chen, zhenle qin, Zhicheng Jin, Guofu Wang |
| 14 |
[GO] |
2023―Oct―13 |
Usnic acid based thiazole-hydrazones as multi-targeting inhibitors of a wide spectrum of SARS-CoV-2 viruses |
Olga I. Yarovaya, Aleksandr S. Filimonov, Dmitriy S. Baev, Sophia S. Borisevich, Varvara Yu. Chirkova, Anna V. Zaykovskaya, Ekaterina D. Mordvinova, Svetlana V. Belenkaya, Dmitriy N. Shcherbakov, Olga A. Luzina, Oleg V. Pyankov, Nariman F. Salakhutdinov |
| 15 |
[GO] |
2023―Sep―29 |
Hydrogen-bond-assisted topochemical synthesis of a multivalent zwitterionic tetramer via concomitant cross- and homo [2+2] photocycloadditions. Theoretical antiviral activity against SARS-CoV-2 |
Ana M. Escalona, Frank Heinemann, Alexander Ovidio Briceno, Ysaias Alvarado, José Paz, Carla Lossada, Lenin Gozález-Paz, Robert Antonio Toro, Jose Henao |
| 16 |
[GO] |
2023―May―22 |
An ultrasensitive electrochemiluminescence immunosensor for SARS-CoV-2 nucleocapsid protein detection based on signal amplification strategy of DMSN@QDs |
Shasha Feng, Fubin Pei, Wei Hu, Zhiwei Liu, Bin Du, Xihui Mu, Bing Liu, Qingli Hao, Wu Lei, Zhaoyang Tong |
| 17 |
[GO] |
2023―Feb―10 |
Ecofriendly aminochalcogenation of alkenes: a green alternative to obtain compounds with potential anti SARS-CoV-2 activity |
Luana Da Silva Gomes, Jose Neto, Iris Di Leo, Cecilia Gomes Barbosa, Carolina Borsoi Moraes, Lucio Freitas Junior, Bruno Rizzuti, Claudio Santi, Vanessa Nascimento |
| 18 |
[GO] |
2023―Jan―05 |
New nickel(ii) Schiff base complexes as potential tools against SARS-CoV-2 Omicron target proteins: an in silico approach |
Sunil Kumar, Mukesh Choudhary |
| 19 |
[GO] |
2023―Jan―04 |
Biphenyl furanocoumarin compounds inhibit SARS-CoV-2 spike pseudovirus infection by binding ACE2 |
Yuexin Lv, Shuai Ge, Qiumei Zhu, Min Si, Cheng Wang, Huaizhen He |
| 20 |
[GO] |
2022―Nov―16 |
Emerging membrane technologies and disinfection methods for efficient removal of waterborne pathogens during COVID-19 pandemic and post-pandemic |
Shadpour Mallakpour, Elham Azadi, Chaudhery Mustansar Hussain |
| 21 |
[GO] |
2022―Oct―25 |
Tailoring the electrocatalytic activity of porous carbon with heteroatom dopants for the quantification of COVID-19 frontline medicine in pharmaceuticals and biological samples |
Narmatha Sivaraman, Vel Duraisamy, Sakkarapalayam Murugesan Senthil Kumar, R. Thangamuthu |
| 22 |
[GO] |
2022―Sep―05 |
Identification of pyridine derivative of diselenides as potent inhibitor of main protease of SARS-CoV-2 through in silico screening and biochemical evaluation |
Beena G Singh, Vishwa V. Gandhi, Prasad P Phadnis, Amit Kunwar |
| 23 |
[GO] |
2022―Jun―29 |
Development of an Actinium-225 Radioimmunoconjugate for Targeted Alpha Therapy against SARS-CoV-2 |
Roger M. Pallares, Matthew Flick, Katherine M Shield, Tyler A Bailey, Nileena Velappan, Antonietta M Lillo, Rebecca Abergel |
| 24 |
[GO] |
2022―May―27 |
Casiopeinas® as SARS-CoV-2 main protease (Mpro) inhibitors. A combined DFT, molecular docking and ONIOM approach |
Miguel Reina, Luis Gabriel Talavera Contreras, Yeshenia Figueroa De Paz, Lena Ruiz-Azuara, Luis Hernández Ayala |
| 25 |
[GO] |
2022―Apr―04 |
Label-Free and Reagentless Electrochemical detection of nucleocapsid protein of SARS-CoV-2: An ultrasensitive and Disposable Biosensor |
Elif Burcu Aydin, Muhammet Aydin, Mustafa Kemal Sezgintürk |
| 26 |
[GO] |
2022―Feb―22 |
Synthesis and characterization of novel copper(ii) complexes as potential drug candidates against SARS-CoV-2 main protease |
Sunil Kumar, Mukesh Choudhary |
| 27 |
[GO] |
2021―Dec―22 |
A graphene-printed paper electrode for determination of H2O2 in municipal wastewater during the COVID-19 pandemic |
Tushar Kant, Kamlesh Shrivas, Indrapal Karbhal, Sanjay Yadav, Sushama Sahu, Yugal Kishor Mahipal, Vellaichamy Ganesan |
| 28 |
[GO] |
2021―Dec―21 |
Quantum Design of Transition Metals Decorated on Boron Phosphide Inorganic Nanocluster for Favipiravir Adsorption: A Possible Treatment for Covid-19 |
Muhammad Ramzan Saeed Ashraf Janjua |
| 29 |
[GO] |
2021―Sep―10 |
Adsorption of chloroquine and hydroxychloroquine as potential drugs for SARS-CoV-2 infection on BC3 nanosheets: a DFT study |
Rezvan Rahimi, Mohammad Solimannejad, Mohadeseh Farghadani |
| 30 |
[GO] |
2021―Sep―10 |
Design and Synthesis of De Novo Boomerang Shaped Molecules and their In Silico & SERS-based Interactions with SARS-CoV-2 Spike Protein and ACE2 |
Amrutham Linet, Manu M Joseph, Haritha Mambatta, Shamna k, Sunil varughese, Parukuttyamma Sujatha Devi, CH Suresch, Kaustabh Maiti, Ishita Neogi |
| 31 |
[GO] |
2021―Jul―24 |
Proposing high-affinity inhibitors from Glycyrrhiza glabra L. against SARS-CoV-2 infection: Virtual screening and computational analysis |
Mina Maddah, Roodabeh Bahramsoltani, Nafiseh Hoseini Yekta, Roja Rahimi, Rasoul Aliabadi, Mahdi Pourfath |
| 32 |
[GO] |
2021―Jul―21 |
Modeling the Interaction of SARS-CoV-2 Binding to the ACE2 Receptor by Molecular Theory of Solvation |
Alexander E Kobryn, Yutaka Maruyama, Carlos A. Velázquez-Martínez, Norio Yoshida, Sergey Gusarov |
| 33 |
[GO] |
2021―May―17 |
The computational approach of designing novel SARS-CoV-2 Mpro inhibitors: combined QSAR, molecular docking, and molecular dynamics simulation techniques |
Jianbo Tong, Ding Luo, Haiyin Xu, Shuai Bian, Xing Zhang, Xuechun Xiao, Jie Wang |
| 34 |
[GO] |
2021―Apr―21 |
Fight against COVID-19 pandemic with the help of carbon-based nanomaterials |
Shadpour Mallakpour, Elham Azadi, Chaudhery Mustansar Hussain |
| 35 |
[GO] |
2021―Apr―14 |
Computational analysis of Macrolides as SARS-CoV-2 Main Protease Inhibitors: A Pattern Recognition Study Based on Molecular Topology and validated by Molecular Docking |
Riccardo Zanni, Maria Galvez-Llompart, Jorge Galvez |
| 36 |
[GO] |
2021―Apr―01 |
Toward an efficient and eco-friendly route for the synthesis of dimeric 2,4-diacetyl phloroglucinol and its potential as a SARS-CoV-2 main protease antagonist insight from in silico studies |
Triana Kusumaningsih, Wahyu Eko Prasetyo, Fajar Rakhman Rakhman Wibowo, Maulidan Firdaus |
| 37 |
[GO] |
2021―Mar―03 |
The latest strategists for the fight against COVID-19 pandemic: The role of metals and metal oxides nanoparticles |
Shadpour Mallakpour, Elham Azadi, Chaudhery Mustansar Hussain |
| 38 |
[GO] |
2020―Dec―09 |
Nitric oxide as a therapeutic option for COVID-19 treatment: a concise perspective |
Jan Mohammad Mir, R. C. Maurya |
| 39 |
[GO] |
2020―Nov―18 |
Transition metal complexes as the potential tools against SARS-CoV-2: In silico approach |
Maynak Pal, Dulal Musib, Mithun Roy |
| 40 |
[GO] |
2020―Oct―12 |
Two Antioxidant 2,5-Disubstituted-1,3,4-oxadiazoles (CoViTris2020 and ChloViD2020): Striking Successful Repurposing against COVID-19 as the First Potent Multitarget Anti-SARS-CoV-2 Drugs |
Amgad M. Rabie |
| 41 |
[GO] |
2020―Aug―31 |
Molecular docking reveals the potential of Cleome amblyocarpa isolated compounds to inhibit COVID-19 virus main protease |
Ahmed Zaki, Ahmed A. Al-Karmalawy, Yasser El-Amier, Ahmed Ashour |
| 42 |
[GO] |
2020―Jul―01 |
GS-5734: FDA potentially approved drug against SARS-Cov-2 |
Zhonglei Wang, Liyan Yang |
| 43 |
[GO] |
2020―May―08 |
Whole Genome Sequence Analysis and Homology Modelling of Main Protease and Non-Structural Protein 3 of the SARS-CoV-2 reveals an Aza-Peptide and a Lead Inhibitor with Possible Antiviral Properties |
Arun K Shankar, Divya Bhanu, Anjani Alluri, Samriddhi Gupta |
